# Purple Biotech LTD.: Form 20-F for the period ended Dec 31, 2025

- Company: [Purple Biotech LTD.](/companies/ppbt.md) (CIK 1614744)
- Form: 20-F
- Filed: 2026-03-19
- Accepted by EDGAR: Mar 18, 2026, 21:11 ET
- Period: 2025-12-31
- Accession: 0001213900-26-031365
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$26.4m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | $0.03 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | $0.03 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | −$5.7m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $3.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2025-12-31 | $8.7m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2025-12-31 | $9.9m | ifrs-full:CurrentAssets |
| Total assets | at 2025-12-31 | $17.6m | ifrs-full:Assets |
| Current liabilities | at 2025-12-31 | $7.8m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2025-12-31 | $9.7m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2025-12-31 | 1,858,911,801 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm

Filed Mar 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-031365. Last ingested by Listed: Nov 12, 2026, 22:01 ET. No prices; not investment advice.